Previous Section Index Home Page

9 May 2007 : Column 262W—continued


Ambulance Services: Rural Areas

Daniel Kawczynski: To ask the Secretary of State for Health what assessment her Department has made of the effectiveness of experienced ambulance control room staff in saving lives and minimising risks to patients in rural areas. [135185]

Andy Burnham: No assessment has been made of the effectiveness of experienced ambulance control room staff in saving lives and minimising risks to patients in rural areas.

However, national health service ambulance trust control room staff play an important role in ensuring that responses to 999 calls are dispatched promptly, that calls are prioritised accurately and that callers receive the advice and reassurance that they need. For example, call handlers can give callers advice on dealing with childbirth, uncontrolled bleeding or resuscitation while they wait for help to arrive. This advice is routinely provided no matter where the control room or the caller is located.

Asthma

Mr. Andrew Smith: To ask the Secretary of State for Health (1) what plans she has for the provision of specialist asthma healthcare staff and care plans; [136065]

(2) what studies her Department has undertaken of the variations in rates of admission for asthma attacks across primary care trusts; [136066]

(3) what steps her Department is taking (a) to improve preventative provision for asthma and (b) to reduce the need for asthma-related emergency admissions. [136074]

Mr. Ivan Lewis [holding answer 8 May 2007]: The Department published “Supporting People with Long-term Conditions: An NHS and Social Care Model” in January 2005. The purpose of the model is to improve the health and quality of life of people with long-term conditions, including asthma, by providing:

The new general medical services contract was launched in February 2003. The contract includes a specific quality indicator for treatment and care of people with asthma based on:


9 May 2007 : Column 263W

We are not aware of the Department’s having undertaken any studies of the variation in admission rates across primary care trusts.

It is the responsibility of local health bodies to ensure they have adequate staff with the skills necessary to meet the health needs of their local population.

Brain Tumours

John Bercow: To ask the Secretary of State for Health how much funding has been provided by her Department for research into brain tumours in 2006-07. [129877]

Caroline Flint: The Department funds research to support policy and to provide the evidence needed to underpin quality improvement and service
9 May 2007 : Column 264W
development in the national health service. The Department’s national research programme spend on projects related to brain tumour in 2006-07 is £868,000. This figure includes expenditure in two areas where the focus is on paediatric oncology as a whole. It excludes expenditure from the research and development allocations made annually to NHS providers. That information is not held centrally.

John Bercow: To ask the Secretary of State for Health if she will list the brain tumour studies being supported by her Department; how much funding has been provided to each study by her Department; and how many (a) children and (b) adults are taking part in these studies. [129878]

Caroline Flint: The information available is shown in the table.


9 May 2007 : Column 265W

9 May 2007 : Column 266W
National Cancer Research Network (NCRN) supported brain tumour studies—Adult brain tumour patients
Title Research Funder Status Recruitment

BR12: Temozolomide vs PCV chemotherapy in the treatment of recurrent malignant glioma

Cancer Research UK (CR-UK)/Medical Research Council (MRC)

Recruiting

351

BR 14: A randomised controlled trial of temozolomide as adjuvant and/or concurrent treatment in anaplastic (WHO grade III) glioma

European Organisation for Research and Treatment of Cancer (EORTC)/Schering Plough

In set-up

0

Primary chemotherapy with temozolomide vs. radiotherapy in patients with low grade gliomas with stratification for genetic 1p loss: a phase III study

EORTC/ Schering Plough

In set-up

0

No Radiotherapy versus Whole Brain Radiotherapy for 1 to 3 Brain Metastases from Solid Tumor after Surgical Resection or Radiosurgery. A Randomized Phase III Trial

EORTC

In set-up

0

Phase III Trial comparing Conventional Adjuvant Temozolomide with Dose Intensive Temozolomide in Patients with Newly Diagnosed Glioblastoma

EORTC

In set-up

0

BR11: Adjuvant procarbazine, CCNU and vincristine chemotherapy in patients with highly anaplastic oligodendroglioma

MRC

Closed, in follow-up

368

Multicentre, Phase II Study of Carboplatin pre-irradiation in patients with primary glioblastoma multiforme following biospy

Closed, in follow-up

25 (closed early)

Childhood brain tumour patients

Hyperfractionated accelerated radiotherapy (HART) with chemotherapy (cisplatin, CCNU, vincristine) for metastatic (M1-3) Medulloblastoma

CR-UK

Recruiting

18

A Prospective randomised controlled trial of hyperfractionated versus conventionally fractionated radiotherapy in standard risk medulloblastoma

CR-UK

Recruiting

18

Phase II study of the combination of Cisplatin + Temozolomide in malignant glial tumours in children and adolescents at diagnosis or in relapse

CR-UK

Recruiting

15

Cooperative Multicentre Study For Children And Adolescents With Low Grade Glioma

CR-UK

Recruiting

111

Magnetic Resonance Spectroscopy of Brain Tumours

CR-UK

Recruiting

48

Magnetic Resonance Spectroscopy of Brain Stem Tumours

CR-UK

Recruiting

7

An in depth study over time on the effect of child and parent factors on the perceived quality of life of children treated for a brain tumour

Samantha Dickson Research Trust Brain Tumour UK

Recruiting

47

Phase I Studies of TARCEVA (erlotinib Hydrochloride, OSI-774) as Single Agent in Children with Refractory and Relapsed Malignant Brain Tumours and in Combination with Irradiation in Newly Diagnosed Brain Stem Glioma

CR-UK

Recruiting

0

CNS 1992 04 (Infant Brain Tumours) Use of high-field strength MR derived biomarkers in prostate cancer: Potential for improved cancer staging and prognostication

CR-UK

Closed, in follow-up

213

Study of Paediatric Low Grade Gliomas

CR-UK

Closed, in follow-up

798

Treatment of children with newly diagnosed diffuse pontine gliomas using conventional radiotherapy and high dose tamoxifen

CR-UK

Closed, in follow-up

31

SIOP Intracranial Germ Cell TumoursI

CR-UK

Closed, in follow-up

137

Comparison of Hair regrowth in children with localised PNETs of the posterior fossa (medulloblastoma) treated with surgery followed by radiotherapy or chemotherapy and radiotherapy

CR-UK

Closed, in follow-up

75


The Department’s allocation to the NCRN in 2006-07 is £14.5 million. It is not possible to say what part of this support funding is spent on individual projects.

Details of a number of other non-NCRN studies supported from the allocations made by the Department to national health service research active organisations can be found on the National Research Register at

Care Homes

Mr. Hepburn: To ask the Secretary of State for Health how many (a) care homes and (b) care home beds there were in (i) the Jarrow constituency, (ii) South Tyneside, (iii) the North East and (iv) England in each year since 1997. [134850]

Mr. Ivan Lewis: Information for the Jarrow constituency is not centrally available.

Table 1 shows the number of care homes open and places available in England, the North East region, and South Tyneside and Gateshead area for adults aged 18 and over, at 31 March for the years 1997 to 2001. Data for 2002 are not available. Data for 2001 are not comparable to 2003 data.

Table 1: Number of care homes( 1) open and places available for adults aged 18 and over, at 31 March, 1997 to 2001
England North East region South Tyneside and Gateshead( 2)
Homes Places Homes Places Homes Places

1997

28,800

534,400

1,300

31,700

170

4,100

1998

29,000

553,500

1,400

34,000

190

4,500

1999

28,700

546,200

1,400

33,400

190

4,200

2000

28,300

539,200

1,400

32,800

180

4,200

2001

27,500

528,000

1,400

31,100

190

4,100

(1 )Includes residential homes, nursing homes, mental nursing homes and private hospitals/clinics.
(2 )Nursing care relates to Gateshead and South Tyneside Health Authority; residential care relates to Gateshead and South Tyneside councils with social services responsibilities. Data for South Tyneside alone was not collected until 2003, with the establishment of the National Care Standards Commission and later the Commission for Social Care Inspection (CSCI) to register and inspect social care providers.
Source:
RA and RH(N) returns

Table 2 shows the number of care homes and places registered in England, the North East region and South Tyneside for adults aged 18 and over, at 31 March for the years 2003 to 2007.

Table 2: Number of care homes( 1) open and places available for adults aged 18 and over, at 31 March, 2003 to 2007
England North East region South Tyneside
Homes Places Homes Places Homes Places

2003(2)

20,038

434,637

1,017

25,899

53

1,491

2004

19,502

445,732

1,014

26,405

52

1,519

2005

19,033

440,886

1,003

26,658

54

1,669

2006

18,718

441,335

962

25,690

49

1,561

2007

18,577

441,958

951

25,866

47

1,492

(1) Includes care homes with nursing, adult placement, non-medical and personal care.
(2) Excludes some local authority homes, which were open but not registered.
Source:
CSCI registration and inspection database. Data as at 26 April 2007.

Next Section Index Home Page